Literature DB >> 11245819

Development of tolerance to nicotine's anxiogenic effect in the social interaction test.

E E Irvine1, S Cheeta, S E File.   

Abstract

The purpose of the present experiment was to explore the role of the dorsal hippocampus in mediating the development of tolerance to the anxiogenic effect of nicotine in the social interaction test of anxiety, and to determine whether tolerance develops to the effects of nicotine on [3H]-5-HT release in this area. Nicotine (1 microg) administered bilaterally into the dorsal hippocampus significantly reduced the time spent in social interaction in vehicle pre-treated rats, indicating an anxiogenic effect, but tolerance to this effect was seen in the rats pre-treated for 6 days with s.c. nicotine (0.1 mg/kg/day). In rats that had been pre-treated with vehicle for 6 days, nicotine (50-200 microM), significantly stimulated [3H]-5-HT release from dorsal hippocampal slices. This stimulation was significantly reduced in rats pre-treated with nicotine (0.1 mg/kg/day) for 6 days, indicating the development of tolerance to the effects of nicotine on 5-HT release. This suggests that tolerance to the anxiogenic effect of nicotine administered into the dorsal hippocampus could be mediated by a reduction in the nicotine enhancement of 5-HT release in this area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245819     DOI: 10.1016/s0006-8993(01)01984-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Acute stress and nicotine cues interact to unveil locomotor arousal and activity-dependent gene expression in the prefrontal cortex.

Authors:  Craig A Schiltz; Ann E Kelley; Charles F Landry
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Withdrawal from chronic nicotine in adolescent and adult rats.

Authors:  Carrie E Wilmouth; Linda P Spear
Journal:  Pharmacol Biochem Behav       Date:  2006-12-14       Impact factor: 3.533

3.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

4.  Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens.

Authors:  Ben Chang; Claire A Daniele; Keith Gallagher; Michelle Madonia; Robert D Mitchum; Lindy Barrett; Paul Vezina; Daniel S McGehee
Journal:  J Neurophysiol       Date:  2011-05-18       Impact factor: 2.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.